
Early detection of MS activity is crucial for disease management and patient outcomes.


coremsg

Roche's Elecsys NfL test is intended to be used as an aid in detection of disease activity in adults with relapsing-remitting multiple sclerosis or secondary progressive multiple sclerosis.

Blood Test for MS Activity Gets FDA Breakthrough Designation

fda-grants-breakthrough-designation-to-roche-s-elecsys-neurofilament-light-chain-test-for-ms


FDA Grants Breakthrough Designation to Roche's Elecsys Neurofilament Light Chain Test for MS
